Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and ...
The IFA has formally called on the Federal Trade Commission to shift its focus away from increased regulation of the franchise business model, arguing that the commission's recent actions exceed its ...